Drugplain

Talzenna 1 mg/1

talazoparib · CAPSULE · Pfizer Laboratories Div Pfizer Inc

No Recall History
Plain English

Talzenna is a capsule containing talazoparib at 1 mg/1, taken oral. Manufactured by Pfizer Laboratories Div Pfizer Inc.

Key Facts

Brand Name
Talzenna
Generic Name
talazoparib
NDC Code (Product)
0069-1195
Manufacturer
Pfizer Laboratories Div Pfizer Inc
Strength
1 mg/1
Dosage Form
CAPSULE
Route
ORAL
Marketing Status
Application #
NDA211651
Marketing Start
10/26/2018

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

anaemia263 reports
neoplasm progression171 reports
death170 reports
fatigue115 reports
off label use96 reports
thrombocytopenia94 reports
haemoglobin decreased78 reports
platelet count decreased73 reports
febrile neutropenia68 reports
malignant neoplasm progression67 reports

Frequently Asked Questions

What is Talzenna used for?

Talzenna contains talazoparib. It is a capsule taken oral. Consult your doctor for specific uses.

Is Talzenna a controlled substance?

Talzenna is not classified as a controlled substance by the DEA.

What is the generic name for Talzenna?

The generic name for Talzenna is talazoparib. There are no other listed brand versions of talazoparib.

What is the NDC code for Talzenna 1 mg/1?

The NDC (National Drug Code) for Talzenna 1 mg/1 is 0069-1195, listed by Pfizer Laboratories Div Pfizer Inc.

Product NDC

0069-1195

Package NDC

0069-1195-30

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)